Molecular analysis of plasma alpha 1.3-fucosyltransferase deficiency and development of the methods for its genotyping

Citation
S. Tanaka et al., Molecular analysis of plasma alpha 1.3-fucosyltransferase deficiency and development of the methods for its genotyping, EXP CLIN IM, 18(1), 2001, pp. 1-12
Citations number
42
Categorie Soggetti
Molecular Biology & Genetics
Journal title
EXPERIMENTAL AND CLINICAL IMMUNOGENETICS
ISSN journal
02549670 → ACNP
Volume
18
Issue
1
Year of publication
2001
Pages
1 - 12
Database
ISI
SICI code
0254-9670(2001)18:1<1:MAOPA1>2.0.ZU;2-S
Abstract
Four patients with mental illness were found to be deficient in plasma alph a1,3-fucosyltransferase for the first time in Japan [Exp Clin Immunogenet 1 999;16:125-130]. Complete sequencing of FUT6 genes in these individuals rev ealed the presence of two point mutations, i.e., G739 to A (Glu-->247 to Ly s) and C945 to A (Tyr-->315 to stop). In addition to two reported alleles h aving G739 to A (pf1) and G739 to A and C945 to A (pf3), a new mutated alle le having C945 to A (pf2) was found to be present and all the individuals w ho lack alpha1,3-fucosyltransferase activity in plasma were found to posses s pf genes homozygously (pf/pf). In order to detect such lethal mutations i n FUT6 genes easily, PCR-RFLP methods have also been developed and applied for the screening of FUT6 deficiency in a large number of samples which res ulted in the demonstration of three additional fUT6-deficient individuals. The absence of alpha1,3-fucosylated molecules on alpha (1)-acid glycoprotei n in plasma from all the 7 individuals was confirmed to result from the pla sma alpha1,3-fucosyltransferase deficiency. Copyright (C) 2001 S. Karger AG . Basel.